<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Microbiology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>17</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>02</Month>
        <Day>05</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Immunological efficiency of Haemophilus influenzae type b polyribosyl ribitol phosphate combined with detoxified lipooligosaccharide in a rabbit model</title>
    <FirstPage>106</FirstPage>
    <LastPage>112</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Amin</FirstName>
        <LastName>Arsang</LastName>
        <affiliation locale="en_US">Department of Mycobacteriology &amp; Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Davar</FirstName>
        <LastName>Siadat</LastName>
        <affiliation locale="en_US">Department of Mycobacteriology &amp; Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Masoumeh</FirstName>
        <LastName>Saberpour</LastName>
        <affiliation locale="en_US">Department of Influenza and Other Respiratory Viruses, Pasteur Institute of Iran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farshad</FirstName>
        <LastName>Nojoomi</LastName>
        <affiliation locale="en_US">Infectious Diseases Research Center, AJA University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>07</Month>
        <Day>26</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>24</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Haemophilus influenzae type b (Hib)&#xA0;could cause severe life-threatening infections in children. Combine vaccines have reduced invasive diseases, but disease management is still necessary. The aim of this research was to evaluate the immunological efficiency of polyribosyl-ribitol-phosphate combined with detoxified lipooligosaccharide (PRP-dLOS) in a rabbit model.
Materials and Methods: PRP purification, LOS extraction, and endotoxin evaluation were performed using modified CY medium, hot phenol, and limulus amebocyte lysate methods, respectively. Rabbit groups were immunized with PRP (10 &#xB5;g), dLOS (20 &#xB5;g), and PRP-dLOS combine (10 &#xB5;g+20 &#xB5;g) three times on days 0, 14, and 28. Serum samples were acquired on days 0, 14, and 28 post-immunization, then IgM and IgG levels were assayed by enzyme-linked immunosorbent assay.
Results: The concentrations of PRP, dLOS, and endotoxin were 1160 mg/L, 440 &#x3BC;g/mL, and 1450 EU/mL, respectively. PRP-dLOS combine led to a significant increase in IgG and IgM levels on days 14 and 28 post-immunization. After immunization with PRP-dLOS combine, serum levels of IgM and IgG increased from 16.8 to 29.3 &#xB5;g/mL and 29.8 to 61.4 &#xB5;g/mL, respectively from day 14 to day 28.
Conclusion: PRP-dLOS combine is a promising approach for Hib management without the fear of delay in immune responses and interference with other vaccines.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/3250</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/3250/1747</pdf_url>
  </Article>
</Articles>
